Regenxbio Inc (RGNX) Stock Rating Upgraded by Zacks Investment Research – The Cerbat Gem

Posted: April 29, 2017 at 2:47 am


Sports Perspectives
Regenxbio Inc (RGNX) Stock Rating Upgraded by Zacks Investment Research
The Cerbat Gem
The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for the treatment of homozygous familial hypercholesterolemia which uses the AAV8 ...
Vittal Vasista Sells 3100 Shares of Regenxbio Inc (RGNX) StockTranscript Daily

all 14 news articles »

View post:
Regenxbio Inc (RGNX) Stock Rating Upgraded by Zacks Investment Research - The Cerbat Gem

Related Posts

Comments are closed.

Archives